Skip to main content
. Author manuscript; available in PMC: 2020 Nov 16.
Published in final edited form as: Mol Cancer Res. 2020 Mar 19;18(5):735–747. doi: 10.1158/1541-7786.MCR-19-0018

Figure 1. PAD4 expression in human and mouse mammary tumors.

Figure 1.

(A) Meta-analysis of gene expression profiling for PAD4 where the colored squares indicate the median rank for PAD4 across each analysis. PAD4 ranks in the top 10% to 25% in all 5 analyses. (B) Relative protein expression of PAD4 assessed in cancer cell lines by Western blot with antibody against PAD4. (C) Quantification of PADI4 in 4T1 cells by comparison to known amounts of purified PAD4 protein.